Malaria Treatment: INE963 Study

We are investigating a new compound, INE963, to see how safe it is and how well it works for treating malaria. This study will help us understand how the body handles this new treatment.

6-12 monthsSafety phase (I)Infectious DiseasesInternal Medicine

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Pharma Bio-Research Group
Program Management
Groningen, Netherlands
Sponsor: Novartis Pharma AG
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.